[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
June 19, 2018

For Patients With Type 2 Diabetes, What’s the Best Target Hemoglobin A1C?

JAMA. 2018;319(23):2367-2369. doi:10.1001/jama.2018.5420

Medical organizations are at odds over new guidance that recommends easing hemoglobin A1C (HbA1c) targets for patients with type 2 diabetes. The updated guidance statement from the American College of Physicians (ACP), which focuses on glycemic control with medications, says clinicians should personalize goals and aim to achieve an HbA1c level of between 7% and 8% for most patients with type 2 diabetes.